World News

22057 readers

141 users here now

Breaking news from around the world.

News that is American but has an international facet may also be posted here.

Guidelines for submissions:

Where possible, post the original source of information.
- If there is a paywall, you can use alternative sources or provide an archive.today, 12ft.io, etc. link in the body.
Do not editorialize titles. Preserve the original title when possible; edits for clarity are fine.
Do not post ragebait or shock stories. These will be removed.
Do not post tabloid or blogspam stories. These will be removed.
Social media should be a source of last resort.

These guidelines will be enforced on a know-it-when-I-see-it basis.

For US News, see the US News community.

This community's icon was made by Aaron Schneider, under the CC-BY-NC-SA 4.0 license.

founded 2 years ago

MODERATORS

224

Ozempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5 (fortune.com)

submitted 7 months ago by Five@slrpnk.net to c/news@beehaw.org

34 comments fedilink hide all child comments

you are viewing a single comment's thread
view the rest of the comments

[–] teawrecks@sopuli.xyz 25 points 7 months ago (2 children)

Wonder how much public funding was used toward the research.

[–] GenEcon@lemm.ee 5 points 7 months ago (1 children)

You can look it up: https://www.novonordisk.com/partnering-and-open-innovation/open-innovation/private-public-partnerships.html

[–] underisk@lemmy.ml 7 points 7 months ago* (last edited 7 months ago) (1 children)

nothing on this page mentions anything about Ozempic, semaglutide, or the amounts of funding received. the closest thing is a list of current diabetes research projects with, again, no amounts listed and no clear relation to ozempic.